Amedeo Smart

Free Medical Literature Service


 

Amedeo

Gastric Cancer

  Free Subscription

Articles published in
Br J Surg
    July 2022
  1. LIU K, Zhang WH, Hu JK
    Comment on: Impact of postoperative chemotherapy on survival for oesophagogastric adenocarcinoma after preoperative chemotherapy and surgery.
    Br J Surg. 2022;109:e91.
    >> Share

  2. RAHMAN SA, Underwood TJ
    Author response to: Impact of postoperative chemotherapy on survival for oesophagogastric adenocarcinoma after preoperative chemotherapy and surgery.
    Br J Surg. 2022;109:e92.
    >> Share

    February 2022
  3. SILVA ANS, Saito Y, Yoshikawa T, Oshima T, et al
    Increasing frequency of gene copy number aberrations is associated with immunosuppression and predicts poor prognosis in gastric adenocarcinoma.
    Br J Surg. 2022;109:291-297.
    >> Share

  4. RAHMAN S, Thomas B, Maynard N, Park MH, et al
    Impact of postoperative chemotherapy on survival for oesophagogastric adenocarcinoma after preoperative chemotherapy and surgery.
    Br J Surg. 2022;109:227-236.
    >> Share

    November 2021
  5. RAHMAN SA, Maynard N, Trudgill N, Crosby T, et al
    Prediction of long-term survival after gastrectomy using random survival forests.
    Br J Surg. 2021;108:1341-1350.
    >> Share

    October 2021
  6. CHMELO J, Phillips AW, Greystoke A, Bradshaw A, et al
    Comparison of the effects of FLOT and ECX chemotherapy for oesophagogastric adenocarcinoma on cardiopulmonary reserve.
    Br J Surg. 2021;108:e328-e329.
    >> Share

    September 2021
  7. ZHENG-YAN L, Feng Q, Yan S, Ji-Peng L, et al
    Learning curve of robotic distal and total gastrectomy.
    Br J Surg. 2021;108:1126-1132.
    >> Share

  8. BONNOT PE, Lintis A, Mercier F, Benzerdjeb N, et al
    Prognosis of poorly cohesive gastric cancer after complete cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (CYTO-CHIP study).
    Br J Surg. 2021 Sep 9. pii: 6366963. doi: 10.1093.
    >> Share

  9. PARK DJ, Kim YW, Yang HK, Ryu KW, et al
    Short-term outcomes of a multicentre randomized clinical trial comparing laparoscopic pylorus-preserving gastrectomy with laparoscopic distal gastrectomy for gastric cancer (the KLASS-04 trial).
    Br J Surg. 2021 Sep 6. pii: 6364812. doi: 10.1093.
    >> Share

    June 2021
  10. ALKHAFFAF B, Metryka A, Blazeby JM, Glenny AM, et al
    Core outcome set for surgical trials in gastric cancer (GASTROS study): international patient and healthcare professional consensus.
    Br J Surg. 2021 Jun 24. pii: 6308782. doi: 10.1093.
    >> Share

  11. PHILLIPS AW, Griffin SM
    Three decades of oesophagogastric cancer care: now a curable disease.
    Br J Surg. 2021;108:595-597.
    >> Share

    May 2021
  12. JIN C, Jiang Y, Yu H, Wang W, et al
    Deep learning analysis of the primary tumour and the prediction of lymph node metastases in gastric cancer.
    Br J Surg. 2021;108:542-549.
    >> Share

    March 2021
  13. KOEMANS WJ, van der Kaaij RT, van Sandick JW
    Reply to Correspondence to "Treatment of PERItoneal dissemination in Stomach Cancer patients with cytOreductive surgery and hyperthermic intraPEritoneal chemotherapy (HIPEC): first results of the PERISCOPE I study".
    Br J Surg. 2021;108:e94.
    >> Share

  14. CHIU CC, Lee PH, Chang CS, Rau KM, et al
    Correspondence to 'Treatment of PERItoneal disease in Stomach Cancer with cytOreductive surgery and hyperthermic intraPEritoneal chemotherapy: PERISCOPE I initial results'.
    Br J Surg. 2021;108:e93.
    >> Share

    January 2021
  15. KAMARAJAH SK, Navidi M, Phillips AW
    Response to "Comment on: Impact of anastomotic leak on long-term survival in patients undergoing gastrectomy for gastric cancer".
    Br J Surg. 2021 Jan 31. pii: 6124825. doi: 10.1093.
    >> Share

  16. HU Q, Sun Y, Yang X
    Comment on: Impact of anastomotic leak on long-term survival in patients undergoing gastrectomy for gastric cancer.
    Br J Surg. 2021 Jan 31. pii: 6124822. doi: 10.1093.
    >> Share

    November 2020
  17. LIU Y, Yang T, Wei YW
    What is the difference between overall survival, recurrence-free survival and time-to-recurrence?
    Br J Surg. 2020;107:e634.
    >> Share

    October 2020
  18. HUANG J, Yang B, Tan J, Zhou S, et al
    Gastric cancer nodal tumour-stroma ratios influence prognosis.
    Br J Surg. 2020 Oct 14. doi: 10.1002/bjs.12054.
    >> Share

  19. JESTIN HANNAN C, Linder G, Kung CH, Johansson J, et al
    Geographical differences in cancer treatment and survival for patients with oesophageal and gastro-oesophageal junctional cancers.
    Br J Surg. 2020;107:1500-1509.
    >> Share

  20. VAN DER KAAIJ RT, Wassenaar ECE, Koemans WJ, Sikorska K, et al
    Treatment of PERItoneal disease in Stomach Cancer with cytOreductive surgery and hyperthermic intraPEritoneal chemotherapy: PERISCOPE I initial results.
    Br J Surg. 2020;107:1520-1528.
    >> Share

    September 2020
  21. JIN C, Jiang Y, Yu H, Wang W, et al
    Deep learning analysis of the primary tumour and the prediction of lymph node metastases in gastric cancer.
    Br J Surg. 2020 Sep 29. doi: 10.1002/bjs.11928.
    >> Share

  22. KAMARAJAH SK, Phillips AW
    Author response: Anastomotic leak does impact on long-term survival in gastric cancer patients.
    Br J Surg. 2020 Sep 21. doi: 10.1002/bjs.11944.
    >> Share

  23. KAMARAJAH SK, Phillips AW
    Author response to: Comment on: Impact of anastomotic leak on long-term survival in patients undergoing gastrectomy for gastric cancer.
    Br J Surg. 2020 Sep 21. doi: 10.1002/bjs.11953.
    >> Share

  24. DIAO YK, Jia HD, Huang DS, Zhang CW, et al
    Comment on: Impact of anastomotic leak on long-term survival in patients undergoing gastrectomy for gastric cancer.
    Br J Surg. 2020 Sep 21. doi: 10.1002/bjs.11954.
    >> Share

    August 2020
  25. LIN JP, Zhao YJ, He QL, Hao HK, et al
    Adjuvant chemotherapy for patients with gastric neuroendocrine carcinomas or mixed adenoneuroendocrine carcinomas.
    Br J Surg. 2020;107:1163-1170.
    >> Share

    June 2020
  26. KAMARAJAH SK, Navidi M, Griffin SM, Phillips AW, et al
    Impact of anastomotic leak on long-term survival in patients undergoing gastrectomy for gastric cancer.
    Br J Surg. 2020 Jun 13. doi: 10.1002/bjs.11749.
    >> Share

  27. AN JY, Min JS, Hur H, Lee YJ, et al
    Laparoscopic sentinel node navigation surgery versus laparoscopic gastrectomy with lymph node dissection for early gastric cancer: short-term outcomes of a multicentre randomized controlled trial (SENORITA).
    Br J Surg. 2020 Jun 3. doi: 10.1002/bjs.11655.
    >> Share

    May 2020
  28. RI M, Nunobe S, Honda M, Akimoto E, et al
    Gastrectomy with or without omentectomy for cT3-4 gastric cancer: a multicentre cohort study.
    Br J Surg. 2020 May 20. doi: 10.1002/bjs.11702.
    >> Share

    February 2020
  29. ROH CK, Choi S, Seo WJ, Cho M, et al
    Indocyanine green fluorescence lymphography during gastrectomy after initial endoscopic submucosal dissection for early gastric cancer.
    Br J Surg. 2020 Feb 7. doi: 10.1002/bjs.11438.
    >> Share

  30. LU J, Zhao YJ, Zhou Y, He Q, et al
    Modified staging system for gastric neuroendocrine carcinoma based on American Joint Committee on Cancer and European Neuroendocrine Tumor Society systems.
    Br J Surg. 2020;107:248-257.
    >> Share

    January 2020

  31. Randomized clinical trial of extensive intraoperative peritoneal lavage versus standard treatment for resectable advanced gastric cancer (CCOG 1102 trial).
    Br J Surg. 2020;107:120.
    >> Share

  32. SAUNDERS JH, Yanni F, Dorrington MS, Bowman CR, et al
    Impact of postoperative complications on disease recurrence and long-term survival following oesophagogastric cancer resection.
    Br J Surg. 2020;107:103-112.
    >> Share

    November 2019
  33. DATTA J, Da Silva EM, Kandoth C, Song T, et al
    Poor survival after resection of early gastric cancer: extremes of survivorship analysis reveal distinct genomic profile.
    Br J Surg. 2019 Nov 25. doi: 10.1002/bjs.11443.
    >> Share

    October 2019
  34. MISAWA K, Mochizuki Y, Sakai M, Teramoto H, et al
    Randomized clinical trial of extensive intraoperative peritoneal lavage versus standard treatment for resectable advanced gastric cancer (CCOG 1102 trial).
    Br J Surg. 2019 Oct 1. doi: 10.1002/bjs.11303.
    >> Share

    August 2019
  35. ALLUM WH, Smyth EC, Blazeby JM, Grabsch HI, et al
    Quality assurance of surgery in the randomized ST03 trial of perioperative chemotherapy in carcinoma of the stomach and gastro-oesophageal junction.
    Br J Surg. 2019;106:1204-1215.
    >> Share

  36. LIN JX, Yoon C, Desiderio J, Yi BC, et al
    Development and validation of a staging system for gastric adenocarcinoma after neoadjuvant chemotherapy and gastrectomy with D2 lymphadenectomy.
    Br J Surg. 2019;106:1187-1196.
    >> Share

    June 2019

  37. Snapshot quiz.
    Br J Surg. 2019;106:878.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016